Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BGLC BioNexus Gene Lab	$5.63 -1.6%	$5.07	$2.01 ▼ $15.60	$10.13M	5.34	3.08 million shs	31,788 shs
DHAC Digital Health Acquisition	$0.82 -5.7%	$1.17	$11.07 ▼ $33.08	$2.96M	0.23	40,215 shs	67,551 shs
MGRX Mangoceuticals	$1.73 +4.2%	$1.68	$1.32 ▼ $7.66	$18.23M	2.42	86,807 shs	101,857 shs
SSY SunLink Health Systems	$1.12 +16.6%	$1.04	$0.62 ▼ $1.91	$7.88M	1.16	145,367 shs	243,934 shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BGLC BioNexus Gene Lab	0.00%	+5.43%	+14.90%	+91.50%	+33.25%
DHAC Digital Health Acquisition	0.00%	+4.86%	-39.71%	-24.77%	-52.05%
MGRX Mangoceuticals	0.00%	+5.49%	0.00%	+2.37%	-97.20%
SSY SunLink Health Systems	0.00%	0.00%	-17.72%	+31.65%	+38.15%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BGLC BioNexus Gene Lab	0.0284 of 5 stars	0.0	2.0	0.0	0.0	0.4	0.0	0.0
DHAC Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MGRX Mangoceuticals	0.7038 of 5 stars	0.0	2.0	0.0	0.0	2.5	1.7	0.6
SSY SunLink Health Systems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
BGLC BioNexus Gene Lab	N/A	N/A	N/A
DHAC Digital Health Acquisition	N/A	N/A	N/A
MGRX Mangoceuticals	N/A	N/A	N/A
SSY SunLink Health Systems	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BGLC BioNexus Gene Lab	$9.51M	1.07	N/A	N/A	$4.63 per share	1.22
DHAC Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
MGRX Mangoceuticals	$620K	29.41	N/A	N/A	$4.30 per share	0.40
SSY SunLink Health Systems	$31.09M	0.25	N/A	N/A	$2.27 per share	0.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BGLC BioNexus Gene Lab	-$1.60M	N/A	0.00	∞	N/A	-30.70%	-35.54%	-29.08%	N/A
DHAC Digital Health Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MGRX Mangoceuticals	-$8.71M	-$3.86	N/A	∞	N/A	-2,757.86%	-85.01%	-78.08%	N/A
SSY SunLink Health Systems	-$1.53M	$0.24	4.66	∞	N/A	5.55%	-18.98%	-14.79%	N/A

Latest DHAC, BGLC, SSY, and MGRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/18/2025	Q2 2025	BGLC BioNexus Gene Lab	N/A	-$0.34	N/A	-$0.34	N/A	$2.26 million
8/14/2025	Q2 2025	MGRX Mangoceuticals	N/A	-$0.57	N/A	-$0.57	N/A	$0.17 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BGLC BioNexus Gene Lab	N/A	N/A	N/A	N/A	N/A
DHAC Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A
MGRX Mangoceuticals	N/A	N/A	N/A	N/A	N/A
SSY SunLink Health Systems	N/A	N/A	N/A	N/A	N/A

Latest DHAC, BGLC, SSY, and MGRX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2025	SSY SunLink Health Systems	special	$0.10			7/29/2025	7/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BGLC BioNexus Gene Lab	N/A	3.63	2.94
DHAC Digital Health Acquisition	N/A	N/A	N/A
MGRX Mangoceuticals	N/A	0.07	0.07
SSY SunLink Health Systems	N/A	3.91	3.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BGLC BioNexus Gene Lab	18.85%
DHAC Digital Health Acquisition	1.01%
MGRX Mangoceuticals	56.72%
SSY SunLink Health Systems	23.67%

Insider Ownership

Company	Insider Ownership
BGLC BioNexus Gene Lab	0.70%
DHAC Digital Health Acquisition	6.59%
MGRX Mangoceuticals	16.00%
SSY SunLink Health Systems	27.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BGLC BioNexus Gene Lab	30	1.80 million	1.78 million	Not Optionable
DHAC Digital Health Acquisition	2,021	3.60 million	3.37 million	Not Optionable
MGRX Mangoceuticals	3	10.54 million	8.85 million	Not Optionable
SSY SunLink Health Systems	1,376	7.04 million	5.08 million	Not Optionable

DHAC, BGLC, SSY, and MGRX Headlines

Recent News About These Companies

Sunlink Health Systems Completes Merger with Regional Health

August 14, 2025 | msn.com

Regional Health Properties, Inc. and SunLink Health Systems, Inc. ...

August 4, 2025 | gurufocus.com

Regional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for Merger

August 4, 2025 | businesswire.com

Regional Health Properties, Inc. and SunLink Health Systems, Inc. ...

August 4, 2025 | gurufocus.com

SunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger With Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDT

July 29, 2025 | businesswire.com

A Closer Look at SunLink’s (SSY) Special Dividend

July 26, 2025 | msn.com

Sunlink Health Systems Receives NYSE American Deficiency Notice

July 26, 2025 | theglobeandmail.com

SunLink Health Systems updates on planned special cash dividend

July 24, 2025 | msn.com

SunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDT

July 24, 2025 | businesswire.com

SunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.

July 24, 2025 | businesswire.com

SunLink Health Systems, Inc Declares Special Cash Dividend Prior to with the Proposed Merger with Regional Health Properties, Inc.

July 21, 2025 | businesswire.com

SunLink Health Systems Declares 10c Special Div

July 19, 2025 | marketwatch.com

SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing ... - Morningstar

July 8, 2025 | morningstar.comM

SunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing Standards

July 7, 2025 | businesswire.com

Sunlink Health Systems Extends Merger Agreement Deadline

June 23, 2025 | tipranks.com

SunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter Results

May 13, 2025 | businesswire.com

REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION

April 15, 2025 | markets.businessinsider.com

SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results

February 12, 2025 | businesswire.com

Regional Health Properties to merge with Sunlink Health Systems

January 8, 2025 | mcknightsseniorliving.comM

Regional Health, SunLink Health to merge in all-stock transaction

January 7, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DHAC, BGLC, SSY, and MGRX Company Descriptions

BioNexus Gene Lab NASDAQ:BGLC

$5.63 -0.09 (-1.57%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.50 -0.13 (-2.22%)

As of 05:28 AM Eastern

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Digital Health Acquisition NASDAQ:DHAC

$0.82 -0.05 (-5.75%)

As of 08/22/2025

Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.

Mangoceuticals NASDAQ:MGRX

$1.73 +0.07 (+4.22%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$1.63 -0.10 (-5.55%)

As of 04:05 AM Eastern

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

SunLink Health Systems NYSE:SSY

$1.12 +0.16 (+16.56%)

Closing price 08/14/2025

Extended Trading

$1.12 0.00 (0.00%)

As of 08/14/2025 08:00 PM Eastern

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time